---
title: "Microbix Biosystems Secures CAP Order for Quality Assessment Products"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275453525.md"
datetime: "2026-02-10T12:02:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275453525.md)
  - [en](https://longbridge.com/en/news/275453525.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275453525.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275453525.md) | [繁體中文](https://longbridge.com/zh-HK/news/275453525.md)


# Microbix Biosystems Secures CAP Order for Quality Assessment Products

Microbix Biosystems Inc. has announced that it has begun supplying its quality assessment products (QAPs) to the College of American Pathologists (CAP) for use in CAP’s clinical laboratory proficiency-testing (PT) and external quality assessment (EQA) programs. The company confirmed that multiple QAP product SKUs have been provided to CAP and are being used at clinical laboratories participating in CAP PT/EQA programs. The specific programs using Microbix QAPs remain confidential to maintain the integrity of the proficiency testing process. Microbix aims to support additional CAP PT/EQA programs and expand its offerings in the future. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbix Biosystems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1134904) on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [MBX Biosciences, Inc. (MBX.US)](https://longbridge.com/en/quote/MBX.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [Direxion Daily S&P Biotech Bear 3X ETF (LABD.US)](https://longbridge.com/en/quote/LABD.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [Rapid Micro Biosystems, Inc. (RPID.US)](https://longbridge.com/en/quote/RPID.US.md)
- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)

## Related News & Research

- [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/en/news/281390073.md)
- [Telomir seeks FDA approval for Telomir-1 to treat breast cancer](https://longbridge.com/en/news/281346305.md)
- [Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update](https://longbridge.com/en/news/281525623.md)
- [Perimeter Posts Record 2025 Revenue and Wins FDA Approval for AI Breast Imaging Device](https://longbridge.com/en/news/281274047.md)
- [InSilico Medicine Strikes Multi-Billion-Dollar AI Drug Discovery Deal With Eli Lilly](https://longbridge.com/en/news/280909399.md)